A 48-year-old woman with hepatitis C virus-related cirrhosis and a 55-year-old man with primary biliary cholangitis (PBC)-related cirrhosis both present with portal hypertension. Which feature best distinguishes PBC-related cirrhosis from HCV-related cirrhosis?

Explanation

## Distinguishing PBC-Related from HCV-Related Cirrhosis ### Pathognomonic Features of PBC **Key Point:** Primary biliary cholangitis is characterized by autoimmune destruction of intrahepatic bile ducts, with antimitochondrial antibodies (AMA) being present in >95% of cases. This autoimmune cholestasis is the defining feature that distinguishes PBC from HCV-related cirrhosis. ### Comparative Pathology | Feature | PBC-Related Cirrhosis | HCV-Related Cirrhosis | |---------|----------------------|----------------------| | **Antimitochondrial antibodies (AMA)** | Present (>95%) | Absent | | **Bile duct destruction** | Characteristic (early) | Absent | | **Lymphoid aggregates/follicles** | Mild to moderate | Prominent (hallmark) | | **Hepatitis C antibodies** | Negative | Positive | | **Steatosis** | Minimal | Often present | | **Portal inflammation** | Moderate | Often severe | | **Granulomas** | Present (around ducts) | Absent | ### Histological Hallmarks of PBC **High-Yield:** The diagnostic triad of PBC includes: 1. **Bile duct destruction** — Loss of intrahepatic bile ducts (>50% loss = stage 3–4) 2. **Granulomatous inflammation** — Non-caseating granulomas around damaged ducts 3. **Autoimmune markers** — AMA-M2 (against pyruvate dehydrogenase complex) ### Histological Hallmarks of HCV **High-Yield:** HCV cirrhosis is characterized by: 1. **Lymphoid aggregates/follicles** — B-cell-rich collections in portal tracts (pathognomonic) 2. **Steatosis** — Often present, correlates with viral load 3. **Bile duct proliferation** — Reactive, not destructive 4. **Minimal granulomas** — Absent or very rare ### Serological Discrimination **Clinical Pearl:** - **PBC:** AMA-M2 positive (>95%), anti-centromere antibodies (ACA) in 50%, anti-sp100 in 25% - **HCV:** HCV antibody positive, HCV RNA detectable by PCR These serology results, combined with histology showing bile duct destruction in PBC versus lymphoid aggregates in HCV, provide definitive discrimination. ### Why Other Features Are Non-Discriminatory - **Hepatitis C antibodies and lymphoid aggregates:** While these are characteristic of HCV, they do not distinguish PBC from HCV—they only confirm HCV etiology - **Elevated direct bilirubin and jaundice:** Both conditions can present with cholestasis and jaundice as cirrhosis progresses; this is not discriminatory - **Ascites and splenomegaly:** These are manifestations of portal hypertension from any cirrhosis etiology and are not specific to either condition [cite:Robbins 10e Ch 18]